Examples of using Aprepitant in English and their translations into Swedish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
-
Political
Do not take Aprepitant powder if you.
EMEND 40 mg hard capsules Aprepitant.
Aprepitant is also an inducer of CYP2C9.
EMEND 165 mg hard capsules Aprepitant.
Aprepitant has been studied at higher doses.
People also translate
Effect of other medicinal products on the pharmacokinetics of aprepitant.
Aprepitant is not excreted unchanged in urine.
Difference(%) calculated as Aprepitant 40 mg minus Ondansetron 4 mg.
Aprepitant after fosaprepitant administration.
Emend is a medicine containing the active substance aprepitant.
Aprepitant is excreted in the milk of lactating rats.
Twelve metabolites of aprepitant have been identified in human plasma.
Aprepitant is a substrate
The pharmacological effect of fosaprepitant is attributed to aprepitant.
Effect aprepitant on the pharmacokinetics of other active substances.
There were no margins to clinically relevant exposure of aprepitant.
Elimination Aprepitant is not excreted unchanged in urine.
vomiting associated with chemotherapy- aprepitant.
Effect of aprepitant on the pharmacokinetics of other active substances.
correlate well with aprepitant plasma concentrations.
Aprepitant, used to prevent nausea
No clinically relevant differences in aprepitant pharmacokinetics is expected due to age and gender.
Emend(aprepitant)- Conditions
Effect of other medicinal products on the pharmacokinetics of aprepitant resulting from administration of fosaprepitant 150 mg.
When fosaprepitant is used concomitantly with another CYP3A4 inhibitor, aprepitant plasma concentrations could be elevated.
Concomitant intake of a 40 mg dose with a standard breakfast decreased the aprepitant Cmax by 18% but did not affect AUC.
Infusion of 100 mg fosaprepitant over 15 minutes with diltiazem 120 mg 3 times daily, resulted in a 1.5-fold increase of aprepitant AUC.
have been reported after aprepitant and ifosfamide co-administration.
Patients had the opportunity to receive open-label aprepitant in subsequent cycles(Optional Cycles 2-6);
IVEMEND 150 mg(N=1,147) was compared with a 3-day aprepitant regimen(N=1,175) in patients receiving a HEC regimen that included cisplatin≥70 mg/m2.